Uguen, T. et al. 2012. First description of an uterine perforation potentially imputable to treatment with bevacizumab. Acta Oncologica. 51, 8 (Nov. 2012), 1102–1104. DOI:https://doi.org/10.3109/0284186X.2012.689855.